Does intravenous immunoglobulin prevent primary cytomegalovirus disease in kidney transplant recipients?
Khawand
N
N
Department of Transplantation Services, Washington Hospital Center, Washington, DC 20010.
Light
J A
JA
Brems
W
W
Aquino
A
A
Ali
A
A
D000328:Adult; D000914:Antibodies, Viral / Q000032:analysis; D002986:Clinical Trials as Topic; D003587:Cytomegalovirus / Q000276:immunology / Q000302:isolation & purification; D003586:Cytomegalovirus Infections / Q000175:diagnosis / Q000517:prevention & control*; D004797:Enzyme-Linked Immunosorbent Assay; D006801:Humans; D007074:Immunoglobulin G / Q000008:administration & dosage*; D007167:Immunotherapy; D016030:Kidney Transplantation; D008875:Middle Aged; D014019:Tissue Donors
D000914:Antibodies, Viral; D007074:Immunoglobulin G